News Results
There are 980,542 News Results
Jul 18, 2017
- Results from 4,000 Participants re: Impact of Brain Amyloid Imaging on Medical Management -
Oct 11, 2017
INDIANAPOLIS, Oct. 12, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation for its New...
Nov 13, 2017
PAR Technology Corporation (NYSE: PAR) (the “Company”) today announced its results of continuing operations for its third quarter ended September 30, 2017.
Nov 13, 2017
RARITAN, N.J. and ANAHEIM, Calif., Nov. 14, 2017 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced a new analysis from the CANVAS Program, which showed INVOKANA(®) (canagliflozin) demonstrated...
Nov 15, 2017
DUBLIN, Ohio, Nov. 16, 2017 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched its new
Feb 25, 2018
INDIANAPOLIS, Feb. 26, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved Verzenio(TM )(abemaciclib) in combination with an...
Apr 26, 2018
Real-World Study Shows INVOKANA® (canagliflozin) 300mg Demonstrates Better Blood Glucose Control Than Farxiga® (dapagliflozin) 10mg in Patients with Type 2 Diabetes
May 31, 2018
FDA Approves OLUMIANT® (baricitinib) 2-mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis
Jun 24, 2018
TITUSVILLE, N.J. and ORLANDO, Fla., June 24, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced late-breaking results of a new real-world analysis of more than...
Nov 29, 2018
INDIANAPOLIS, Nov. 29, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the upcoming presentation of clinical data at the 2018 San Antonio Breast Cancer Symposium (SABCS) in...
